These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10356737)

  • 21. Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice.
    Sangdee K; Waropastrakul S; Wongratanachewin S; Homchampa P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1190-6. PubMed ID: 22299445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes.
    Peacock SJ; Limmathurotsakul D; Lubell Y; Koh GC; White LJ; Day NP; Titball RW
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1488. PubMed ID: 22303489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
    Titball RW; Burtnick MN; Bancroft GJ; Brett P
    Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combating the great mimicker: latest progress in the development of
    Khakhum N; Chapartegui-González I; Torres AG
    Expert Rev Vaccines; 2020 Jul; 19(7):653-660. PubMed ID: 32669008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.
    Scott AE; Laws TR; D'Elia RV; Stokes MG; Nandi T; Williamson ED; Tan P; Prior JL; Atkins TP
    Clin Vaccine Immunol; 2013 Jul; 20(7):1041-7. PubMed ID: 23677322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of and immunity to melioidosis.
    Brett PJ; Woods DE
    Acta Trop; 2000 Feb; 74(2-3):201-10. PubMed ID: 10674650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challenge.
    Puangpetch A; Anderson R; Huang YY; Saengsot R; Sermswan RW; Wongratanacheewin S
    Vaccine; 2014 Oct; 32(45):5983-8. PubMed ID: 25223269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis.
    Burtnick MN; Shaffer TL; Ross BN; Muruato LA; Sbrana E; DeShazer D; Torres AG; Brett PJ
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29109172
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis.
    Schully KL; Bell MG; Prouty AM; Gallovic MD; Gautam S; Peine KJ; Sharma S; Bachelder EM; Pesce JT; Elberson MA; Ainslie KM; Keane-Myers A
    Int J Pharm; 2015 Nov; 495(2):849-61. PubMed ID: 26428631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 32. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.
    Nieves W; Petersen H; Judy BM; Blumentritt CA; Russell-Lodrigue K; Roy CJ; Torres AG; Morici LA
    Clin Vaccine Immunol; 2014 May; 21(5):747-54. PubMed ID: 24671550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of immunobiological activity of Francisella tularensis C-complex preparations as promising component of subunit vaccines].
    Volokh OA; Shepelev IA; Firsova VV; Khramkova EM; Avdeeva NG; Samokhvalova IuI; Eremin SA; Diatlov IA; Zhemchugov VE
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):16-21. PubMed ID: 17672125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melioidosis: where do we stand in the development of an effective vaccine?
    Muruato LA; Torres AG
    Future Microbiol; 2016; 11(4):477-80. PubMed ID: 27081770
    [No Abstract]   [Full Text] [Related]  

  • 35. Melioidosis vaccines.
    Warawa J; Woods DE
    Expert Rev Vaccines; 2002 Dec; 1(4):477-82. PubMed ID: 12901586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel multi-component vaccine approaches for Burkholderia pseudomallei.
    Morici L; Torres AG; Titball RW
    Clin Exp Immunol; 2019 May; 196(2):178-188. PubMed ID: 30963550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus on the development of vaccines against naturally acquired melioidosis.
    Limmathurotsakul D; Funnell SG; Torres AG; Morici LA; Brett PJ; Dunachie S; Atkins T; Altmann DM; Bancroft G; Peacock SJ;
    Emerg Infect Dis; 2015 Jun; 21(6):. PubMed ID: 25992835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
    Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
    J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC.
    Schmidt LK; Orne CE; Shaffer TL; Wilson SM; Khakhum N; Torres AG; Brett PJ; Burtnick MN
    Infect Immun; 2022 Aug; 90(8):e0022222. PubMed ID: 35862715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel gain of function approaches for vaccine candidate identification in Burkholderia pseudomallei.
    Dowling AJ
    Front Cell Infect Microbiol; 2012; 2():139. PubMed ID: 23316481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.